Clinical Trial of the BioMed rTSST-1 Variant Vaccine in Healthy Adults

NCT02814708 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Toxic Shock Syndrome

Interventions

BIOLOGICAL: rTSST-1v

Sponsor

Biomedizinische Forschungs gmbH

Collaborators

[object Object]